Ibandronate Sodium Catalog No.:M8787-2 2005 Sep 30
USD119.00
USD160.00
Pay in 4 interest-free payments of $29.75 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Live Spec
Ibandronate Sodium Catalog No.:M8787-2 2005 Sep 30Ibandronate sodium is a potent bisphosphonate drug developed by Hoffman La Roche and used in the prevention and treatment of osteoporosis and metastasis associated skeletal fractures in people with cancer. It may also be used to treat hypercalcemia (elevated blood calcium levels). Ibandronate is indicated for the treatment and prevention of osteoporosis in post menopausal women. In May 2003, the U. S. Food and Drug Administration (FDA) approved
Store: yutopean.com · Domain: yutopean.com
